Pharmaceutical - Ferring Pharmaceuticals

Filter

Current filters:

Ferring Pharmaceuticals

Popular Filters

Ferring and Roche collaborate to develop personalized infertility treatment

Ferring and Roche collaborate to develop personalized infertility treatment

25-06-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals and Swiss drug major Roche have entered…

Ferring PharmaceuticalsPharmaceuticalReproductiveResearchRocheWomen's Health

UK NICE to hold oral appeal hearing for Ferring’s Firmagon

UK NICE to hold oral appeal hearing for Ferring’s Firmagon

18-06-2014

Privately-held Switzerland-headquartered drugmaker Ferring Pharmaceuticals confirmed today that its drug…

Ferring PharmaceuticalsFirmagonOncologyPharmaceuticalRegulationUK

NICE draft guidance recommends Ferring’s Firmagon for prostate cancer

NICE draft guidance recommends Ferring’s Firmagon for prostate cancer

15-04-2014

In final draft guidance published today, the UK’s National Institute for Health and Care Excellence…

AnatomyCare ExcellenceFerring PharmaceuticalsFirmagonHealth Medical PharmaMedicineOncologyPharmaceuticalRegulationUKUnited Kingdom

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

06-04-2014

US pharma giant Merck & Co and privately-held Switzerland-headquartered Ferring Pharmaceuticals have…

carbetocinFerring PharmaceuticalsGlobalMarkets & MarketingMerck & CoPharmaceuticalResearchWomen's Health

UK NICE draft guidance recommends Ferring’s Firmagon for prostate cancer

UK NICE draft guidance recommends Ferring’s Firmagon for prostate cancer

27-12-2013

UK drugs watchdog the National Institute for Health and Care Excellence has issued new draft guidance…

EuropeFerring PharmaceuticalsFirmagonOncologyPharmaceuticalPricingRegulationUK

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

18-12-2013

When it comes to being different, privately-owned Ferring Pharma is proud of its culture of enterprise…

BoardroomFerring PharmaceuticalsInterviewsNorthern EuropePharmaceuticalReproductive

Lower risk of CV Events or deaths in prostate cancer patients treated with degarelix compared to LHRH agonists

18-03-2013

The gonadotropin releasing hormone (GnRH) antagonist degarelix (brand name Firmagon, from Swiss drugmaker…

degarelixFerring PharmaceuticalsFirmagonOncologyPharmaceuticalResearch

Ferring Pharma gains rights for elobixibat from Albireo

05-07-2012

Swiss drugmaker Ferring Pharmaceuticals has entered into a licensing agreement with Albireo AB, a Sweden-based…

AlbireoBiotechnologyelobixibatFerring PharmaceuticalsGastro-intestinalsLicensingPharmaceutical

Eisai and Toyama's iguratimod, and Astellas' Gonax OKed in Japan

03-07-2012

Japanese drug major Eisai (TYO: 4523) and Toyama Chemical have received approval from Japan's Ministry…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmaCareramdegarelixEisaiFerring PharmaceuticalsGonaxiguratimodKolbetOncologyPharmaceuticalRegulationToyama

Kyowa Hakko debuts Poteligeo in Japan; co-promotes Minirinmelt with Ferring

29-05-2012

Japanese drugmaker Kyowa Hakko Kirin (TYO: 4151) says that it has launched Poteligeo (mogamulizumab)…

Asia-PacificFerring PharmaceuticalsGenito-urinaryKyowa Hakko KirinMarkets & MarketingMinirinmeltOncologyPharmaceuticalPoteligeo

Ferring Pharma acquires Cytokine PharmaSciences; Cubist buys Adolor

25-10-2011

Switzerland-based Ferring Pharmaceuticals says that it has completed the purchase of USA-based Cytokine…

AdolorCubist PharmaceuticalsCytokine PharmaSciencesEnteregFerring PharmaceuticalsGastro-intestinalsMergers & AcquisitionsPharmaceuticalReproductive

Company Spotlight

ImmunoGen

ImmunoGen

Back to top